0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > NGFR

NGFR

Brief Information

Name:Low affinity neurotrophin receptor p75NTR
Target Synonym:Gp80-LNGFR,NGF Receptor,Low Affinity Neurotrophin Receptor P75NTR,Nerve Growth Factor Receptor (TNFR Superfamily, Member 16),NGFR,TNFR Superfamily, Member 16,Tumor Necrosis Factor Receptor Superfamily Member 16,CD271,CD271 Antigen,Low Affinity Nerve Growth Factor Receptor,Low-Affinity Nerve Growth Factor Receptor,P75 ICD,Nerve Growth Factor Receptor,P75(NTR),TNFRSF16,P75NTR
Number of Launched Drugs:4
Number of Drugs in Clinical Trials:11
Lastest Research Phase:Approved

Product ListCompare or Buy

Par statut du produit :
Par catégorie de produit :
Par espèce :
Par étiquette :
Par conjugaison :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
CHEK-ATP157 Human HEK293/Human NGFR Stable Cell Line
NGR-H5254 Human Human NGFR / TNFRSF16 Protein, Fc Tag (MALS verified)
NGR-H5254-structure
NGR-H5254-sds
ACRO Quality

Part of Bioactivity data

CHEK-ATP157-Cell-based assay
 NGFR FACS

Expression analysis of human NGFR on HEK293/Human NGFR Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human NGFR Stable Cell Line or negative control cell using PE-labeled anti-human NGFR antibody after fixation with 4% paraformaldehyde.

NGR-H5254-BLI
 NGFR BLI

Loaded Human NGFR Protein, Fc Tag (Cat. No. NGR-H5254) on Protein A Biosensor, can bind Human NT-4, Tag Free (Cat. No. NT4-H5114) with an affinity constant of 1.64 nM as determined in BLI assay (ForteBio Octet Red96e) (QC tested).

NGR-H5254-MALS-HPLC
NGFR MALS images

The purity of Human NGFR Protein, Fc Tag (Cat. No. NGR-H5254) is more than 95% and the molecular weight of this protein is around 115-135 kDa verified by SEC-MALS.

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Cenegermin rhNGF (Dompe Farmaceutici) Approved Dompe Farmaceutici Spa 欧适维, Sentinel, Oxervate EU Keratitis Dompé Pharmaceutici Spa 2017-07-06 Keratitis; Corneal Ulcer; Corneal Diseases; Dry Eye Syndromes; Retinitis Pigmentosa; Eye Diseases; Mental Disorders Details
Mouse nerve growth factor (Wuhan Hiteck Bio-pharmaceutical) Approved Wuhan Hiteck Biological Pharma Co Ltd 金路捷 Mainland China Trauma, Nervous System Wuhan Hiteck Biological Pharma Co Ltd 2002-01-01 Optic Nerve Injuries; Trauma, Nervous System Details
Mouse nerve growth factor (Livzon Group) Approved Livzon Pharmaceutical Group Inc 丽康乐 Mainland China Optic Nerve Injuries Livzon(Group) Pharmaceutical Factory 2010-05-07 Optic Nerve Injuries Details
Mouse nerve growth factor (Staidson Biopharma) Approved Staidson(Beijing) Biopharmaceuticals Co Ltd 苏肽生 Mainland China Optic Nerve Injuries Staidson(Beijing) Biopharmaceuticals Co Ltd 2006-04-11 Diabetic Foot; Optic Nerve Injuries; Peripheral Nerve Injuries Details
Cenegermin rhNGF (Dompe Farmaceutici) Approved Dompe Farmaceutici Spa 欧适维, Sentinel, Oxervate EU Keratitis Dompé Pharmaceutici Spa 2017-07-06 Keratitis; Corneal Ulcer; Corneal Diseases; Dry Eye Syndromes; Retinitis Pigmentosa; Eye Diseases; Mental Disorders Details
Mouse nerve growth factor (Wuhan Hiteck Bio-pharmaceutical) Approved Wuhan Hiteck Biological Pharma Co Ltd 金路捷 Mainland China Trauma, Nervous System Wuhan Hiteck Biological Pharma Co Ltd 2002-01-01 Optic Nerve Injuries; Trauma, Nervous System Details
Mouse nerve growth factor (Livzon Group) Approved Livzon Pharmaceutical Group Inc 丽康乐 Mainland China Optic Nerve Injuries Livzon(Group) Pharmaceutical Factory 2010-05-07 Optic Nerve Injuries Details
Mouse nerve growth factor (Staidson Biopharma) Approved Staidson(Beijing) Biopharmaceuticals Co Ltd 苏肽生 Mainland China Optic Nerve Injuries Staidson(Beijing) Biopharmaceuticals Co Ltd 2006-04-11 Diabetic Foot; Optic Nerve Injuries; Peripheral Nerve Injuries Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Mouse nerve growth factor (Sinobioway Biomedicine) Phase 3 Clinical Sinobioway Biomedicine Co Ltd Diabetic Foot; Optic Nerve Injuries Details
Choroid plexus cell replacement therapy (Living Cell Technologies) Phase 3 Clinical Living Cell Technologies Surgical Wound Infection Details
Recombinant human nerve growth factor (Sichuan ZehaTimes Pharmaceutical) Phase 2 Clinical Sichuan ZehaTimes Pharmaceutical Co Ltd Optic Nerve Injuries Details
Recombinant human nerve growth factor(Sinobioway Biomedicine) SMR001; SMR-001 Phase 2 Clinical Sinobioway Biomedicine Co Ltd Xerophthalmia Details
Recombinant human nerve growth factor (Xintrum Pharmacouticals) rh-NGF Phase 2 Clinical Jiangsu Zhongxin Pharmaceutical Co Ltd Keratitis; Optic Nerve Injuries; Glaucoma, Open-Angle Details
CHF-6467 CHF-6467 Phase 2 Clinical Chiesi Farmaceutici SPA Diabetic Foot Details
Udonitrectag REC-0559; MT-8; REC 0/0559 Phase 2 Clinical Mimetech SRL Keratitis Details
Recombinant human nerve growth factor(Chongqing Kerun Biologic) Phase 1 Clinical Chongqing Kerun Biologic Pharmaceutical Development Co Ltd Keratitis Details
CD4^LVFOXP3 Treg-like cell therapy CD4^LVFOXP3 Phase 1 Clinical Stanford University Polyendocrinopathies, Autoimmune Details
Beta-Nerve Growth Factor, Human (Aalborg University) Phase 1 Clinical Aalborg University Shakespeare Company Pain; Hyperalgesia Details
Recombinant human nerve growth factor (Beijing Tongren Hospital) Phase 1 Clinical Beijing Tongren Hospital, Cmu Optic Nerve Injuries Details
Mouse nerve growth factor (Sinobioway Biomedicine) Phase 3 Clinical Sinobioway Biomedicine Co Ltd Diabetic Foot; Optic Nerve Injuries Details
Choroid plexus cell replacement therapy (Living Cell Technologies) Phase 3 Clinical Living Cell Technologies Surgical Wound Infection Details
Recombinant human nerve growth factor (Sichuan ZehaTimes Pharmaceutical) Phase 2 Clinical Sichuan ZehaTimes Pharmaceutical Co Ltd Optic Nerve Injuries Details
Recombinant human nerve growth factor(Sinobioway Biomedicine) SMR001; SMR-001 Phase 2 Clinical Sinobioway Biomedicine Co Ltd Xerophthalmia Details
Recombinant human nerve growth factor (Xintrum Pharmacouticals) rh-NGF Phase 2 Clinical Jiangsu Zhongxin Pharmaceutical Co Ltd Keratitis; Optic Nerve Injuries; Glaucoma, Open-Angle Details
CHF-6467 CHF-6467 Phase 2 Clinical Chiesi Farmaceutici SPA Diabetic Foot Details
Udonitrectag REC-0559; MT-8; REC 0/0559 Phase 2 Clinical Mimetech SRL Keratitis Details
Recombinant human nerve growth factor(Chongqing Kerun Biologic) Phase 1 Clinical Chongqing Kerun Biologic Pharmaceutical Development Co Ltd Keratitis Details
CD4^LVFOXP3 Treg-like cell therapy CD4^LVFOXP3 Phase 1 Clinical Stanford University Polyendocrinopathies, Autoimmune Details
Beta-Nerve Growth Factor, Human (Aalborg University) Phase 1 Clinical Aalborg University Shakespeare Company Pain; Hyperalgesia Details
Recombinant human nerve growth factor (Beijing Tongren Hospital) Phase 1 Clinical Beijing Tongren Hospital, Cmu Optic Nerve Injuries Details

This web search service is supported by Google Inc.

totop

Laisser un message